Hamamatsu University: Clinical Trials

28 trials sponsored by Hamamatsu University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 10 unknown, 1 recruiting, 1 suspended. 9 Phase 2, 6 Phase 3, 4 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 29Unknown 5, Completed 4
Phase 36Completed 3, Unknown 3
Not applicable4Completed 2, Unknown 2
Phase 42Completed 2

Follow Hamamatsu University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AI-Powered Scoliosis Auto-Analysis System Multicenter Development and Validations
Nude back photo - Spinal Deformity
RecruitingThe University of Hong Kong25002022-05-012026-05-01
A Trial of TTA-121 on Autism Spectrum Disorder
TTA-121 - Autism Spectrum Disorder
Phase 2UnknownHamamatsu University1442018-02-272019-12-20
Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
vonoprazan 20 mg bid, Amoxicillin 500 mg tid, Amoxicillin 750 mg bid - Gastritis Associated With Helicobacter Pylori
Phase 3CompletedHamamatsu University1122016-07-012019-04-09
Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori
Eradication of H. pylori - H. Pylori Infection
Phase 2UnknownHamamatsu University1002016-05-012016-05-04
Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori
rabeprazole-based regimen, esomeprazole^based regimen - H. Pylori Infection
Phase 3CompletedHamamatsu University2002012-07-012017-06-22
Catechin Containing Mask for the Prevention of Influenza Infection
tea catechin extracts - Influenza Infection
Not applicableCompletedUniversity of Shizuoka1802008-12-012009-11-26
The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia
prednisolone 0.5 mg/kg/day for three months, prednisolone 0.5 mg/kg/day for six months - Eosinophilic Pneumonia, Chronic Disease
Phase 4CompletedHamamatsu University502008-06-012014-09-19
Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer
gemcitabine and carboplatin, Gemcitabine - Non-Small Cell Lung Cancer
Phase 2CompletedHamamatsu University602008-03-012011-09-07
Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients
methylprednisolone sodium succinate (mPSL), prednisolone (PSL) - Asthma
Phase 4CompletedHamamatsu University502007-06-012011-09-07
Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
sildenafil, placebo, paclitaxel (taxol) - Non-small Cell Lung Cancer
Phase 2 / Phase 3CompletedHamamatsu University1202007-02-012011-09-07
Effects of Statins on the Pharmacokinetics for Midazolam in Healthy Volunteers
simvastatin, atorvastatin, pitavastatin - Healthy Volunteers
Not applicableCompletedHamamatsu University112006-06-012011-09-07
The Influence of FP-10 on the Eradication Rates of H. Pylori by a Triple Therapy
FP-10 - Helicobacter Pylori
Phase 2 / Phase 3UnknownHamamatsu University1382006-01-012006-01-27
Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
Budesonide,hydrofluoroalkane-beclomethasone dipropionate, Budesonide,hydrofluoroalkane-beclomethasone - Asthma
CompletedHamamatsu University242005-11-012009-03-16
The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia
roxithromycin - Alopecia
Not applicableUnknownHamamatsu University202005-05-012010-07-29
Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer
S-1 - Gastric Cancer, Esophageal Cancer
Phase 2UnknownHamamatsu University2004-01-012006-03-22
Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
rabeprazole, amoxicillin, clarithromycin, metronidazole - Helicobacter Infections, Gastritis
Phase 2 / Phase 3UnknownHamamatsu University2003-08-012006-03-21
Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Lansoprazole, clarithromycin, amoxicillin - Helicobacter Infections, Gastritis
Phase 3UnknownHamamatsu University2962003-04-012006-09-11
Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia
Pergolide (drug) - Schizophrenia, Negative Symptoms
SuspendedHamamatsu University202003-03-012005-09-20
Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer
CDGP/5-FU combined with radiation, Radiotherapy - Esophageal Cancer, Squamous Cell Carcinoma
Phase 2CompletedHamamatsu University332003-01-012009-02-20
Pepsinogens as the Early Marker of H. Pylori Eradication
serum pepsinogen, urea breath test - H. Pylori Infection, Gastric Ulcer
Phase 2CompletedHamamatsu University2001-06-012006-02-01

Showing 20 of 28. Sign in to see all of them.

Conditions studied

Stomach Ulcer (4)  ·  Duodenal Ulcer (3)  ·  Asthma (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Esophageal Neoplasms (2)  ·  Gastritis (2)  ·  Helicobacter Infections (2)  ·  Kidney Failure, Chronic (2)  ·  Stomach Neoplasms (2)  ·  Alopecia (1)  ·  Atherosclerosis (1)  ·  Autism Spectrum Disorder (1)  ·  Carcinoma, Squamous Cell (1)  ·  Chronic Disease (1)  ·  Cognition Disorders (1)

Interventions

Amoxicillin (3)  ·  Clarithromycin (3)  ·  Carboplatin (2)  ·  Metronidazole (2)  ·  Prednisolone (2)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1)  ·  Atorvastatin (1)  ·  BID protein, human (1)  ·  Budesonide (1)  ·  Fluorouracil (1)  ·  Gemcitabine (1)  ·  Interleukin-1 (1)  ·  Interleukin-10 (1)  ·  Lansoprazole (1)  ·  Methylprednisolone Hemisuccinate (1)

Countries

Japan (24)  ·  Hong Kong (1)

Top investigators

Kingo Chida, MD,PhD (4)  ·  Takahisa Furuta, MD, PhD (4)  ·  Naohito Shirai, MD., PhD (2)  ·  Naro Ohashi, MD,PhD (2)  ·  Hidenori Yamasue, MD, PhD (1)  ·  Hiromichi Kumagai, MD (1)  ·  Hiroshi Watanabe, MD,PhD (1)  ·  Hiroshi Yamada, MD,PhD (1)  ·  Jason Pui Yin Cheung, MD, MS (1)  ·  Kazunrai Murakami, MD, PhD (1)  ·  Kingo Chida, MD, PhD (1)  ·  MItsushige Sugimoto (1)  ·  Masahiro Takigawa, M.D. (1)  ·  Naohito Shirai, MD., PhD. (1)  ·  Naro Ohashi, M.D., Ph.D. (1)

Results publications

PMID 19930599, PMID 22705118, PMID 25614171, PMID 35067719, PMID 38461957